BioCentury
ARTICLE | Company News

Aradigm, Grifols deal

June 9, 2014 7:00 AM UTC

Aradigm received a $5 million milestone payment from Grifols under a 2013 deal granting Grifols exclusive, worldwide rights to develop and commercialize Aradigm's formulations of inhaled ciprofloxacin...